BetterLife Pharma (BETRF) Acquisitions (2018 - 2020)
BetterLife Pharma (BETRF) posted Acquisitions of $18775.9 for Q4 2020, down 94.25% on a QoQ basis from $326666.0 in Q4 2018.
Powered by 
Analysis
BetterLife Pharma (BETRF) Acquisitions (2018 - 2020) Analysis & Trends
BetterLife Pharma has reported Acquisitions for 2 years, with the latest figure at $18775.9 in Q4 2020.
- On a quarterly basis, Acquisitions changed N/A year-over-year to $18775.9 in Q4 2020; TTM through Jan 2021 was $345441.9, a N/A change from a year earlier, with the FY2021 full-year figure at $18751.0, changed N/A from the prior year.
- Acquisitions was $18775.9 for Q4 2020 at BetterLife Pharma, down from $326666.0 in the prior quarter.
- The five-year high for Acquisitions was $333333.0 in Q2 2018, with the low at $18775.9 in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 207.01 Bn | 193.02 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.98 Bn | 176.80 Bn | 6.22 Bn | 11.21 Bn |
| 3 | Vertex Pharmaceuticals | 131.45 Bn | 123.60 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.02 Bn | 74.03 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.35 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.69 Bn | 48.55 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.11 Bn | 29.80 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.93 Bn | 30.64 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.21 Bn | 29.21 Bn | 1.16 Mn | - |
| 10 | BetterLife Pharma | 31.61 Mn | 31.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Oct 31, 2020 | 18,775.88 |
| Oct 31, 2018 | 326,666.00 |
| Apr 30, 2018 | 333,333.00 |